financetom
Business
financetom
/
Business
/
Nike's H1 Fiscal Year 2025 Guidance 'Leaves Little to Play for,' RBC Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nike's H1 Fiscal Year 2025 Guidance 'Leaves Little to Play for,' RBC Says
Mar 22, 2024 8:04 AM

10:52 AM EDT, 03/22/2024 (MT Newswires) -- Nike's ( NKE ) outlook for H1 2025 implies no revenue growth for calendar year 2024, which "leaves little to play for in the near

term," RBC Capital Markets said in a note to clients on Friday.

The company is "prudently" projecting sales to be down by low-single-digits for the first six months of its following fiscal year, Nike ( NKE ) Chief Financial Officer Matthew Friend said during a late Thursday conference call to discuss fiscal Q3 financial results, according to a Capital IQ transcript.

The guidance "reflects near-term headwinds from life cycle management of our key product franchises, more than offsetting the scaling of new products as we shift our product portfolio toward newness and innovation," Friend said. "This also continues to reflect the subdued macro outlook around the world."

RBC said that "organizational restructuring [plus] product transition over the next few quarters add further uncertainty and guidance risk in our view."

"We have no doubt Nike ( NKE ) will emerge on the other side a better company in a better phase of its business cycle; however, for now we prefer to follow the momentum, which we believe is stronger at adidas," the investment firm said.

RBC downgraded Nike ( NKE ) to sector perform from outperform and cut the price target to $100 from $110.

Nike ( NKE ) shares were falling more than 8% in recent Friday trading.

Price: 92.20, Change: -8.63, Percent Change: -8.55

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sherwin-Williams names Benjamin Meisenzahl as CFO
Sherwin-Williams names Benjamin Meisenzahl as CFO
Nov 3, 2025
Nov 3 (Reuters) - Sherwin-Williams Company ( SHW ) on Monday named Benjamin Meisenzahl as its chief financial officer, effective January 1, 2026. ...
Playstudios misses Q3 revenue estimates on softness in casino business 
Playstudios misses Q3 revenue estimates on softness in casino business 
Nov 3, 2025
Overview * Playstudios ( MYPS ) Q3 revenue of $57.6 mln missed analyst expectations * Net loss for Q3 widened to $9.1 mln from $3.1 mln last year * Direct-to-consumer revenue increased by 48% yr/yr in Q3 Outlook * Company expects full-year revenue and AEBITDA below previous guidance due to player activity softness * Company focuses on direct-to-consumer growth and...
REIT firm Simon Q3 net income rises 28% on increased occupancy rates, raises dividend by 4.8%
REIT firm Simon Q3 net income rises 28% on increased occupancy rates, raises dividend by 4.8%
Nov 3, 2025
Overview * Simon Q3 net income rises to $606.2 mln from $475.2 mln yr/yr * Real Estate FFO per share increases 5.6% yr/yr to $3.22 * Company raises dividend by 4.8% to $2.20 per share Outlook * Company raises full-year 2025 Real Estate FFO guidance to $12.60-$12.70 per share Result Drivers * OCCUPANCY GAINS - Simon reports increased occupancy rates,...
Hims and Hers beats revenue estimates on strong subscriber growth
Hims and Hers beats revenue estimates on strong subscriber growth
Nov 3, 2025
(Reuters) -Hims and Hers Health ( HIMS ) beat Wall Street estimates for third-quarter revenue on Monday, as the telehealth company added subscribers and expanded its personalized healthcare offerings. The company and rivals have launched programs that offer personalized versions of semaglutide, the active ingredient in weight-loss drug Wegovy, at doses not accessible through the branded manufacturers, following the government's...
Copyright 2023-2026 - www.financetom.com All Rights Reserved